BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10

• Press Releases

  Pfizer’s PREVNAR 20 Selected for Pneumococcal Public Immunization Program in British Columbia

  September 10, 2025

   · 

  4 min read
• Press Releases

  Revelation Biosciences Announces Groundbreaking Top-line Results from PRIME Clinical Study

  September 10, 2025

   · 

  10 min read
• Press Releases

  NanoViricides to Present at the Life Science Executive Partnering (LSX) Congress in Boston on September 17, 2025

  September 10, 2025

   · 

  12 min read
• Press Releases

  Telomir Pharmaceuticals Announces New Cancer Data in Aggressive Human Prostate Cancer Cells Showing Telomir-1 Resets DNA Methylation to Reactivate CDKN2A, a Master Tumor Suppressor, Outperforming Rapamycin and Chemotherapy

  September 10, 2025

   · 

  4 min read
• Press Releases

  Arrivent Presents the Final Analysis of Firmonertinib Monotherapy Data from Global Phase 1b Study in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2025 World Conference on Lung Cancer

  September 10, 2025

   · 

  8 min read
• Press Releases

  Enlivex Announces Issuance of New Patent Application Covering the Use of Allocetra in Patients with Osteoarthritis

  September 10, 2025

   · 

  5 min read
• Press Releases

  Emergent BioSolutions Receives New Contract Modification for ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government, Further Demonstrating Importance of Public Health Preparedness

  September 10, 2025

   · 

  5 min read
• Press Releases

  HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program

  September 10, 2025

   · 

  8 min read
• Press Releases

  NKGen Biotech, Inc. Announces Completion of NKMax Co., Ltd. Acquisition; Gains Full Control of Global Manufacturing and Intellectual Property Assets

  September 10, 2025

   · 

  8 min read
• Press Releases

  Cellectar Biosciences to Participate at Oppenheimer 3rd Annual Targeted Radiopharmaceutical Therapies in Oncology Summit

  September 10, 2025

   · 

  6 min read